Bausch & Lomb appoints new chairman and CEO

Article

Former executives of Schering-Plough, Fred Hassan and Brent Saunders, have taken over the helm at Bausch & Lomb as chairman and CEO respectively.

Former executives of Schering-Plough, Fred Hassan and Brent Saunders, have taken over the helm at Bausch & Lomb as chairman and CEO respectively.

New CEO Saunders, in an interview with Associated Press, said: “The previous management should be commended for all the hard work it did to stabilize this company. I've been involved in a stabilization project myself in my past employer, and I know how difficult that can be. It's time for the company to look to the future with a mission of becoming 'not the biggest' but 'the best company in vision care,” Saunders continued.

“We'll be looking to do some tuck-in acquisitions, focused in looking for new products and new sciences and technologies to advance eye health.”

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.